HECHT BETH (See Remarks) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2025ACC: 0001867096-25-000025
Officer· See Remarks
Since Oct 2021
+340.72K
Net shares
Net buyer
$513.7K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
485K acquired · 144.28K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−45.91K
Price / share
$3.56
Trade value
$163.44K
% of position
3.4%
1/31/2025
1.35M→1.31M
Common Stock
Direct
Shares
−98.38K
Price / share
$3.56
Trade value
$350.21K
% of position
7.5%
1/31/2025
1.31M→1.21M
Common Stock
Direct
Shares
+185K
Price / share
—
Trade value
—
% of position
15.3%
1/31/2025
1.21M→1.39M
Total
Net shares
+40.72K
Net value
-$513.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2025 | F · Tax Withholding | −45.91K | $3.56 | $163.44K | 3.4% | 1.35M | 1.31M |
| Common Stock Direct | 1/31/2025 | F · Tax Withholding | −98.38K | $3.56 | $350.21K | 7.5% | 1.31M | 1.21M |
| Common Stock Direct | 1/31/2025 | A · Award | +185K | — | — | 15.3% | 1.21M | 1.39M |
| Total | +40.72K | -$513.65K | ||||||
Derivative Transactions1
Stock Appreciation Right
Direct
Converts to
Common Stock
300K shares
Shares
+300K
Strike price
3.56
Held after
300K
Exercisable
—
1/31/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Appreciation Right Direct | Common Stock300K shares | 1/31/2025 | A · Award | +300K | 3.56 | — | 300K |